Psychedelics, The Brain, and the Future of Mental Health

atai Life Sciences to Participate in Upcoming May Investor Conference

Clearmind Medicine Announces Clinical Supply Agreement for its Upcoming Clinical Trial

PharmaTher Holdings Submits Fast Track Application to FDA for KETARX™ (Ketamine)...

PT408 – Fireside Project: Harm Reduction Through Free Peer Support

American Medical Association to Issue First New Code for Psychedelic Therapies

Revive Therapeutics Announces Data Safety Monitoring Board Meeting Date on Phase...

Psychedelic Bulletin #136: MindMed Collaborators Share Topline LSD for MDD Results;...

Psychedelics Weekly – Breaking Convention, Decolonizing the Psychedelic Space, and How...

atai Life Sciences Presents Pharmacodynamic Data on GRX-917 in a Late...

Load more